HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases

Histone deacetylases (HDACs) are enzymes that play a key role in the epigenetic regulation of gene expression by remodeling chromatin. Inhibition of HDACs is a prospective therapeutic approach for reversing epigenetic alteration in several diseases. In preclinical research, numerous types of HDAC in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugam, Geetha, Rakshit, Sudeshna, Sarkar, Koustav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688863/
https://www.ncbi.nlm.nih.gov/pubmed/34922087
http://dx.doi.org/10.1016/j.tranon.2021.101312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688863/
https://www.ncbi.nlm.nih.gov/pubmed/34922087
http://dx.doi.org/10.1016/j.tranon.2021.101312

Ejemplares similares